Laboratory Peptides A Multivalent mRNA - LNP Vaccine Protects Against Clostridioides Difficile Infection
UPTATED:2025-04-02 | 8
Hospitalization may lead to Clostridioides difficile infection, which is hard to cure. Alameh et al. have developed a multivalent mRNA - lipid nanoparticle vaccine targeting this bacterium. In animal models, the vaccine induces a strong and lasting immune response, protecting mice from infection without harming the normal microbial community.
This article is original by 快乐阿信. Reproduction is welcome, but please indicate the source when reprinting. The title image is from Unsplash, based on the CC0 protocol. The viewpoint of this article only represents the author himself/herself, and Peptide Factory only provides information storage space services.
Article Comment
Rating:
★
★
★
★
★
No Comment